Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

17:25 IST NSE
Legal & RegulatoryProstarm Info Systems Ltd PROSTARM

Prostarm Info Systems Legal & Regulatory

Prostarm Info Systems Limited received intimation that the Customs Department filed an appeal before the CESTAT, Mumbai, against a prior order. The original order had confirmed no liability for a disputed amount of ₹25.66 Crore. The company is currently evaluating its further course of action regarding this litigation update.

Value
₹25.66 Cr
17:23 IST BSE
Price Movement ClarificationPolo Queen Industrial and Fintech Ltd PQIF

Polo Queen Industrial and Fintech Price Movement Clarification

Polo Queen Industrial and Fintech Limited clarified that recent significant stock price movements are purely market-driven. The management confirmed there is no undisclosed material information or events requiring disclosure under SEBI Regulations. The company remains in compliance with all listing obligations.

17:21 IST BSE
Debt & BorrowingDishman Carbogen Amcis Ltd DCAL

Dishman Carbogen Amcis Debt & Borrowing: ₹135.4 Cr

Dishman Carbogen Amcis Limited submitted its half-yearly statement of private placement of debt securities for the period ended March 31, 2026. The company reported three outstanding NCD series with a total outstanding value of ₹135.38 Crore. This filing ensures regulatory compliance regarding its non-convertible debenture obligations.

Value
₹135.4 Cr
17:18 IST BSE
Board Meeting OutcomeCorporate Merchant Bankers Ltd CMBL

Corporate Merchant Bankers Board Meeting Outcome

Corporate Merchant Bankers Limited held a board meeting on April 10, 2026, approving the appointment of M/s. Dhruvi Patel & Associates as Secretarial Auditor for FY 2025-26. The board also approved a postal ballot for member approval, with electronic voting scheduled from April 11 to May 10, 2026.

Execution
Financial Year 2025-26
17:17 IST BSE
Regulatory ApprovalAstraZeneca Pharma India Ltd ASTRAZEN

AstraZeneca Pharma India Regulatory Approval

AstraZeneca Pharma India Ltd received CDSCO approval to import and market Calquence (Acalabrutinib 100mg) for treating previously untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma. This additional indication expands the drug's therapeutic reach in the Indian market, subject to final statutory approvals.

17:14 IST BSE
Management ChangeLife Insurance Corporation of India LICI

Life Insurance Corporation of India Management Change

Life Insurance Corporation of India has elevated Mr. Diwakar Mohan Mittal to Senior Management Personnel as Additional Executive Director (Customer Relationship Management/Claims/Annuities), effective April 10, 2026. Mr. Mittal joined the Corporation in 1992 and previously served as Chief in the same department at the Central Office.

17:11 IST BSE
Merger & RestructuringMahindra & Mahindra Ltd M&M

Mahindra & Mahindra Merger & Restructuring Worth ₹0.02 Cr

Mahindra & Mahindra Ltd. announced the divestment of its entire 99.04% stake in step-down subsidiary Erkunt Sanayi Anonim Şirketi to Hisarlar Makina Sanayi ve Ticaret A.Ş. and others for ~₹0.02 Crore. The transaction, expected to conclude by July 2026, aligns with the company's capital allocation framework and marks its exit from the foundry business.

Value
₹0.02 Cr
Execution
Expected by 30th July, 2026
17:14 IST BSE
Employee Stock OptionsEmkay Global Financial Services Ltd EMKAY

Emkay Global Financial Services Employee Stock Options

Emkay Global Financial Services Limited allotted 1,47,668 equity shares on April 10, 2026, following the exercise of options under its ESOP 2007 and 2018 schemes. The total transaction value is approximately ₹1.04 Crore. Consequently, the company's paid-up equity share capital increased to 2,63,36,731 shares.

Value
₹1.12 Cr
17:11 IST BSE
Annual General MeetingRekvina Laboratories Ltd VINRKLB

Rekvina Laboratories Annual General Meeting

Rekvina Laboratories Limited held its first EGM of FY2026-27 on April 10, 2026. Shareholders considered resolutions including increasing authorized share capital, altering the Memorandum and Articles of Association, and approving preferential equity allotments for cash and non-cash consideration. The meeting concluded with 17 members present and voting conducted via polling papers.

17:11 IST NSE
Legal & RegulatoryEmbassy Developments Ltd EMBDL

Embassy Developments Legal & Regulatory

Embassy Developments Limited provided an update on its NCLAT hearing regarding a stayed NCLT insolvency order involving a ₹370 crore contingent liability. The NCLAT adjourned the matter to April 17, 2026. Separately, the company reported record FY26 pre-sales of ₹4,631 crore, reflecting strong operational performance despite temporary stock exchange surveillance measures.

Value
₹370.0 Cr